Is Compounded Semaglutide Safe? What You Should Know

Important Disclaimer: Compounded semaglutide is NOT FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded medications. Compounded semaglutide has NOT undergone bioequivalence testing and has NOT been shown to be equivalent in safety or effectiveness to FDA-approved Wegovy or Ozempic. Only FDA-approved semaglutide (Wegovy, Ozempic) has undergone the clinical trials and FDA review that establish those products’ labeled safety and effectiveness. The information below is for educational purposes only and is not medical advice. Talk with a licensed healthcare provider about whether any treatment is right for you.

WARNING: Risk of Thyroid C-Cell Tumors. In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether semaglutide causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Semaglutide is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician right away if you notice a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.

This guide explains how compounded semaglutide is made, how compounding pharmacies are regulated, what “FDA-approved ingredient” does and doesn’t mean, the known risks, and what to look for when evaluating a provider.

What Is Compounded Semaglutide?

Compounded semaglutide is a custom-prepared version of the medication semaglutide, made by a licensed compounding pharmacy for an individual patient based on a prescription, rather than mass-manufactured by a pharmaceutical company like Novo Nordisk (maker of Wegovy and Ozempic).

Compounded semaglutide is not FDA-approved. The FDA has not reviewed any compounded semaglutide product for safety, effectiveness, or quality, and the specific formulation a pharmacy prepares has not undergone the testing required of an FDA-approved drug.

How Compounding Works

Compounding pharmacies obtain semaglutide as a raw active ingredient (the Active Pharmaceutical Ingredient, or API) and combine it with other ingredients to prepare an injectable solution.

The process generally involves:

• Sourcing: Obtaining semaglutide API from a licensed supplier
• Formulation: Combining the active ingredient with sterile solution and any preservatives
• Sterile preparation: Preparing the medication in a controlled, cleanroom environment using aseptic technique
• Quality control: Testing consistent with the pharmacy’s category and applicable USP standards
• Packaging: Filling and labeling sterile vials

Key Differences from Brand-Name

Aspect	Brand-Name (Wegovy/Ozempic)	Compounded Semaglutide
Active Ingredient	Semaglutide	Semaglutide
FDA Approval	Yes (full approval, including the finished product)	No (the finished compounded product is not FDA-approved)
Bioequivalence Testing	Established for the approved product	Not performed; not shown equivalent to the brand
Maker	Novo Nordisk	Compounding pharmacies (per individual prescription)
Pre-filled Pens	Yes	Typically vials that require manual drawing
Insurance Coverage	Sometimes (limited for weight loss)	Rarely

Why Do People Use Compounded Semaglutide?

1. Cost

Cost is a common reason people consider compounded semaglutide. For cost details, see our guide to semaglutide costs without insurance. For Contour’s current pricing, see our product page.

2. FDA-Approved Medications

FDA-approved semaglutide (Wegovy, Ozempic) is available by prescription. Check with your healthcare provider and pharmacy about availability of FDA-approved options.

3. Insurance Limitations

Many insurance plans don’t cover Wegovy for weight loss or require prior authorization, high copays, or restrictive eligibility criteria.

4. Patient-Specific Clinical Need

A licensed prescriber may determine that an individual patient has a specific clinical need that a compounded preparation can address — for example, a tailored dose or a formulation accommodating a documented need that an available manufactured product does not meet. Compounding for an individual patient must be based on a valid prescription and a clinical determination by that patient’s provider.

FDA Regulation of Compounded Medications

Understanding Compounding Pharmacy Regulation

Compounded medications occupy a distinct regulatory space. The FDA does not approve individual compounded preparations the way it approves commercially manufactured drugs. Instead, federal and state law govern the facilities and practices of compounding pharmacies. Importantly, a facility’s registration or a pharmacy’s state license is not the same as FDA approval of the medication itself.

Legal Framework: The Drug Quality and Security Act

The Drug Quality and Security Act (DQSA) of 2013 established two categories of compounding pharmacies with different oversight (Source: FDA):

503A Compounding Pharmacies (Patient-Specific)

• Regulation: State boards of pharmacy, under federal and state law
• Scope: Prepare medications for an individual patient pursuant to a valid prescription
• Standards: Must follow USP standards for compounding, including USP <795> (non-sterile) and USP <797> (sterile) as applicable
• Inspections: State board oversight; FDA retains certain authority
• Use case: Patients with a documented, patient-specific clinical need

Contour works with state-licensed 503A compounding pharmacies that prepare semaglutide for an individual patient pursuant to a valid prescription, under USP <795>/<797> standards. A 503A pharmacy is a legitimate, regulated category — not a red flag. At the same time, working with a state-licensed 503A pharmacy does not mean the medication is FDA-approved or FDA-tested, and Contour does not represent that it is.

What the FDA Does and Doesn’t Do Here

The FDA does:

• Regulate the active ingredients (APIs) used in compounding
• Oversee adverse event reporting from compounding pharmacies
• Set and enforce standards that compounding pharmacies must meet under the law

The FDA does not:

• Approve individual compounded formulations for safety and effectiveness
• Routinely test compounded medications before they reach patients
• Guarantee that a compounded drug is equivalent to an FDA-approved version

503A Compounding Pharmacies

Contour works with WellSync and other state-licensed 503A compounding pharmacies in the WellSync network. Under 503A, a licensed pharmacy compounds medication for an individual patient based on that patient’s valid prescription — a prescriber makes a clinical determination for an individual patient, and the pharmacy prepares that patient’s medication under USP <795>/<797> standards.

A state pharmacy license is a sign that the pharmacy is operating within a regulated framework — it is not FDA approval of the product, and it is not a substitute for it. A 503A pharmacy is a legitimate, regulated category. Working with one does not mean the medication is FDA-approved or FDA-tested, and Contour does not represent that it is.

Quality and Safety Standards

Pharmaceutical-Grade Ingredients

Reputable compounding pharmacies source semaglutide API from suppliers that produce pharmaceutical-grade active ingredients and that generally:

• Register with the FDA as API manufacturers
• Follow cGMP standards for production of the API
• Provide a Certificate of Analysis (CoA) for each lot
• Meet United States Pharmacopeia (USP) purity standards

Sterile Compounding Requirements

Injectable medications like semaglutide must be prepared under sterile conditions consistent with USP Chapter <797> (Source: USP), which addresses:

• Controlled cleanroom environments: Strict air-quality and particle-count controls
• Aseptic technique: Procedures designed to prevent contamination
• Air filtration: High-efficiency filtration to reduce particles and microorganisms
• Validated processes and environmental monitoring: Documented, monitored procedures
• Personnel training: Training and competency assessment for staff

Quality Control Testing

Compounding quality control may include the following, depending on the pharmacy and applicable standards. Note that testing practices and frequency vary, and compounded products are not subject to the FDA’s pre-market product review:

Sterility Testing

Checks that the preparation is free from microorganisms that could cause infection.

Endotoxin Testing

Detects bacterial endotoxins, which can cause fever and other reactions even when a product is sterile.

Potency Testing

Verifies that the semaglutide concentration matches the labeled strength, typically using analytical methods such as HPLC.

pH and Particulate Testing

Confirms appropriate pH for injection and checks for particles that should not be present in an injectable solution.

Is It the Same Medication?

Active Ingredient

The semaglutide molecule itself is the same compound whether it is in a compounded preparation made from pharmaceutical-grade API or in a brand-name product. The chemical structure and mechanism of action of the molecule are the same.

Sharing an active ingredient is not the same as being equivalent. A compounded product is a different finished formulation that has not undergone bioequivalence testing and has not been shown to be equivalent in safety or effectiveness to Wegovy or Ozempic.

Overall Formulation: Different

Wegovy/Ozempic formulation includes:

• Semaglutide (active ingredient)
• Disodium phosphate dihydrate
• Propylene glycol
• Phenol
• Water for injection
• A precise pH buffering system

Compounded semaglutide formulations vary, and may include:

• Semaglutide (active ingredient)
• Bacteriostatic water or sodium chloride solution
• A preservative such as benzyl alcohol
• Other ingredients that vary by pharmacy

Why the Difference Matters

• Stability: Brand-name formulations undergo extensive stability testing; compounded preparations carry shorter beyond-use dates (often 30–90 days)
• Consistency: Formulations can differ between compounding pharmacies
• Dosing: Brand-name pens deliver pre-measured doses; vials require accurate manual measurement
• Unknowns: Because compounded products are not FDA-reviewed and have not been tested for equivalence, their safety and effectiveness profile may differ from the approved product in ways that have not been formally studied

Effectiveness: What the Evidence Does and Doesn’t Show

No Equivalence Has Been Established

There are no head-to-head clinical trials demonstrating that compounded semaglutide is as safe or effective as Wegovy or Ozempic. Compounded semaglutide has not undergone bioequivalence testing and has not been shown to be equivalent to the FDA-approved products. You should not assume it will perform the same way.

Clinical-Trial Results Apply to the Approved Product

Published weight-loss figures — for example, the average results often cited for semaglutide — come from clinical trials of the FDA-approved products (Wegovy and Ozempic). These trial results may not apply to compounded semaglutide, which was not studied in those trials and is a different, non-FDA-approved formulation.

Patient Reports Are Anecdotal

Some clinicians and telehealth programs share patient experiences with compounded semaglutide. These reports are anecdotal and are not controlled clinical evidence. They do not establish that compounded semaglutide is equivalent in safety or effectiveness to the brand-name products.

Factors That Can Affect an Individual’s Results

• Actual potency: If not properly tested, a compounded preparation may contain more or less semaglutide than labeled
• Stability: Improper storage or use past the beyond-use date may reduce potency
• Patient technique: Drawing from a vial requires accurate measurement; errors can cause under- or over-dosing
• Storage: Semaglutide requires refrigeration; improper storage can affect the medication

For general information on expected timelines for the medication, see our week-by-week guide, keeping in mind those figures reflect the FDA-approved products.

Potential Risks of Compounded Semaglutide

1. Not FDA-Approved or Tested for Equivalence

Risk: The finished compounded product has not been reviewed by the FDA and has not been shown to be equivalent in safety or effectiveness to Wegovy or Ozempic.

What helps: Use a licensed pharmacy and a licensed prescriber, and understand the difference between an FDA-approved drug and a compounded preparation.

2. Quality Variability

Risk: Compounding pharmacies do not all maintain the same standards; some may have weaker controls or testing.

What helps: Choose a state-licensed pharmacy that follows USP <797> and documents its quality controls.

3. Contamination

Risk: Improper sterile technique can lead to bacterial or fungal contamination and serious infection.

What helps: Use a pharmacy that performs sterility and endotoxin testing and follows USP <797>.

4. Potency Issues

Risk: A preparation may contain more or less semaglutide than labeled, affecting results or side effects.

What helps: Choose a pharmacy that performs potency testing and can provide a Certificate of Analysis.

5. Dosing Errors

Risk: Drawing from a vial requires accurate measurement; errors can cause incorrect dosing.

What helps: Proper training on measuring and injecting, with clearly marked syringes and careful technique.

6. Counterfeit or Adulterated Products

Risk: Some online sources sell counterfeit products, products with no active ingredient, or products containing harmful substances.

What helps: Only obtain medication through a licensed pharmacy and a valid prescription; avoid unverified international or “research-only” sources.

7. Limited Long-Term Data on Compounded Formulations

Risk: While the semaglutide molecule has been studied, specific compounded formulations have not undergone the testing required of FDA-approved products.

What helps: Work with your provider, report any unexpected reactions, and understand the limits of available data.

What to Look For in a Compounding Pharmacy

If you and your prescriber decide compounded semaglutide is appropriate, the following are things to look for — not a guarantee of any outcome. For approval status, see our guide on whether compounded semaglutide is FDA-approved.

Things to Look For

1. Active State Pharmacy License: Current licensure in good standing with the state board of pharmacy
2. Valid Prescription Required: The pharmacy compounds for an individual patient based on a valid prescription from a licensed provider
3. USP <795>/<797> Compliance: Follows applicable USP standards for non-sterile and sterile compounding
4. Sterility and Potency Testing: Performs and documents appropriate testing for injectable preparations
5. Pharmaceutical-Grade API: Sources semaglutide from FDA-registered API suppliers
6. Documentation on Request: Willing to share quality documentation, such as a Certificate of Analysis

Additional Quality Indicators

• Accreditation: Voluntary accreditation such as PCAB can indicate a commitment to quality standards
• Transparency: Willingness to share test results and quality documentation
• Clean Regulatory Record: No recent warning letters or recalls
• Provider Involvement: Works with licensed healthcare providers for prescriptions and monitoring
• Proper Labeling: Clear labels with strength, beyond-use date, lot number, and storage instructions

Questions to Ask

• “Are you a state-licensed compounding pharmacy in good standing?”
• “Do you compound based on a valid, patient-specific prescription?”
• “Do you follow USP <797> for sterile compounding?”
• “Do you perform sterility and potency testing, and can you provide a Certificate of Analysis?”
• “Where do you source your semaglutide API?”
• “What is the beyond-use date of the compounded semaglutide?”

Red Flags to Avoid

Warning Signs of Unsafe Sources

Be cautious of sources that:

• ❌ Are not licensed pharmacies in the United States
• ❌ Ship from outside the United States with no verifiable oversight
• ❌ Don’t require a valid prescription from a licensed provider
• ❌ Can’t or won’t provide verification of testing or quality documentation
• ❌ Have recent warning letters or recalls
• ❌ Refuse to answer questions about quality and safety
• ❌ Make unrealistic promises (“lose 50 pounds in 2 months guaranteed”)
• ❌ Sell “research-only” or non-pharmaceutical-grade material for human use
• ❌ Don’t use refrigerated shipping for a medication that must be kept cold

Specific Concerns with Online Sources

• Unregulated websites: Sites selling “semaglutide” without verifying it comes from a licensed pharmacy and a valid prescription
• Research-chemical suppliers: Sources selling semaglutide “for research purposes only” (not for human use)
• Unverified international suppliers: Sellers outside any verifiable regulatory oversight
• Counterfeit products: Products labeled as semaglutide that contain little or no active ingredient

Cost vs Quality Considerations

Price Is Not a Safety Test

You may hear that very low prices — for instance, around $100/month — are a sign of a low-quality product. In our view, an unusually low price can be one reason to ask more questions, but it is an opinion and a prompt to investigate, not a safety rule. Price alone does not tell you whether a product is safe, accurately dosed, or properly tested. A low price doesn’t prove a product is unsafe, and a high price doesn’t prove a product is safe.

What matters more than the number is whether the medication comes from a state-licensed pharmacy, based on a valid prescription, with appropriate sterility and potency testing and quality documentation.

For Contour’s current pricing, please see our product page.

Value Beyond Price

Factor	Why It Matters
State Licensure	Pharmacy operates within a regulated framework
Valid Prescription	Compounding tied to an individual patient’s clinical need
Testing	Supports sterility and labeled potency
Medical Oversight	Appropriate dosing and monitoring
Transparency	Access to quality documentation

Our compounded semaglutide program works with state-licensed 503A compounding pharmacies that prepare medication for an individual patient under USP <795>/<797> standards, with licensed provider oversight and quality documentation available on request. Compounded semaglutide is not FDA-approved and has not been shown to be equivalent to Wegovy or Ozempic.

FDA-Approved Semaglutide Information

FDA-Approved Options

FDA-approved semaglutide (Wegovy, Ozempic) is available by prescription from healthcare providers. These are the only semaglutide products that have undergone FDA review for safety and effectiveness.

Important Considerations

• FDA-approved products: Only Wegovy and Ozempic have undergone FDA review
• Clinical-trial data: Published weight-loss results from clinical trials apply to the FDA-approved products and may not apply to compounded semaglutide
• Talk to your provider: Discuss all options, including FDA-approved treatments, with a licensed healthcare provider

Frequently Asked Questions

Is compounded semaglutide FDA-approved?

No. The semaglutide active ingredient is FDA-approved, but no compounded semaglutide product is FDA-approved. The FDA has not reviewed any compounded semaglutide formulation for safety, effectiveness, or quality. A pharmacy’s state license or a facility’s registration is not FDA approval of the medication.

Is compounded semaglutide as effective as Wegovy or Ozempic?

This has not been established. Compounded semaglutide has not undergone bioequivalence testing and has not been shown to be equivalent in safety or effectiveness to Wegovy or Ozempic. Clinical-trial results apply to the FDA-approved products and may not apply to compounded versions. Patient reports are anecdotal, not controlled evidence.

How can I evaluate a compounding pharmacy?

Confirm the pharmacy is state-licensed and in good standing. Verify that it compounds based on a valid prescription, follows USP <797> for sterile compounding, and performs sterility and potency testing. Ask whether it can provide a Certificate of Analysis, and check for any recent warning letters or recalls.

What is a 503A compounding pharmacy?

503A compounding pharmacies prepare medication for an individual patient based on a valid prescription, under state-board oversight and USP <795>/<797> standards. A state pharmacy license indicates the pharmacy operates within a regulated framework — it does not mean the compounded medication is FDA-approved. Contour works with WellSync and other state-licensed 503A compounding pharmacies in the WellSync network.

Can I use compounded semaglutide if I have insurance?

Insurance typically doesn’t cover compounded medications, even when it would cover the brand-name product. Compounded semaglutide is generally a self-pay option.

How long does compounded semaglutide last?

Compounded semaglutide typically carries a beyond-use date of about 30–90 days when refrigerated, shorter than brand-name products, because compounding pharmacies do not perform the extensive stability testing required for longer expiration dates. Always check the beyond-use date and refrigerate as directed.

What FDA-approved options are available?

FDA-approved semaglutide options include Wegovy (for weight management) and Ozempic (for type 2 diabetes). Talk with a licensed healthcare provider about which treatment is appropriate for you. See our comparison guide for more about GLP-1 medications.

Have there been recalls of compounded semaglutide?

Yes. There have been recalls of certain compounded semaglutide preparations for issues such as sterility, labeling, or potency. This underscores the importance of using a licensed pharmacy with appropriate testing. You can check the FDA’s recall database and a pharmacy’s recall history.

How do I know if the semaglutide is pharmaceutical-grade?

Ask the pharmacy for its API supplier information and request a Certificate of Analysis. Reputable pharmacies source from FDA-registered API manufacturers and can provide documentation. If a pharmacy can’t or won’t provide this, that’s a red flag.

Is it safe to switch between compounded and brand-name semaglutide?

Talk with your prescriber before switching. Because compounded products are different formulations that have not been tested for equivalence, do not assume the experience will be the same. Your provider can advise on dosing and monitoring.

Does a lower price mean a product is unsafe?

Not necessarily. Price is not a safety test. An unusually low price can be a reason to ask more questions, but it is not proof of anything on its own. Focus on whether the medication comes from a state-licensed pharmacy, based on a valid prescription, with appropriate testing and documentation.

Conclusion: Making an Informed Choice

Compounded semaglutide is not FDA-approved. It has not undergone bioequivalence testing and has not been shown to be equivalent in safety or effectiveness to Wegovy or Ozempic. The active ingredient is the same molecule, but a compounded product is a different, non-FDA-reviewed formulation, and patient reports about it are anecdotal rather than controlled evidence.

If you and a licensed prescriber decide compounded semaglutide is appropriate for your individual clinical situation, the following can help you evaluate a source:

• ✅ Confirm the pharmacy is state-licensed and in good standing
• ✅ Make sure compounding is based on a valid, patient-specific prescription
• ✅ Confirm USP <797> compliance and appropriate sterility and potency testing
• ✅ Check pharmaceutical-grade API sourcing
• ✅ Review any warning letters or recall history
• ✅ Work with a licensed provider for prescribing and monitoring
• ✅ Ask questions and expect transparent answers

Be cautious of:

• ❌ Unlicensed sources or sellers with no verifiable oversight
• ❌ Sources that don’t require a valid prescription
• ❌ Sources that can’t document testing or quality
• ❌ “Research-only” or non-pharmaceutical-grade material sold for human use

Our compounded semaglutide program works with state-licensed 503A patient-specific compounding pharmacies that prepare medication under USP <795>/<797> standards, with:

• Licensed healthcare provider oversight and consultations
• Pharmaceutical-grade semaglutide from FDA-registered API suppliers
• Sterility and potency testing with quality documentation available on request
• Transparent information about how the medication is prepared

Compounded semaglutide is not FDA-approved and has not been shown to be equivalent to Wegovy or Ozempic. For current pricing, see our product page. For more on how semaglutide works and what to expect, visit our complete semaglutide guide.